Opportunities and Challenges in Translational Research: The Development of Photodynamic Therapy and Anti-Vascular Endothelial Growth Factor Drugs. Issue 1 (2021)

• Record Type: Journal Article
• Authors: Marko, Christina Kaiser; Miller, Joan W.
• Editors: Sarpatwari, Ameet
• Is Part Of: Journal of law, medicine & ethics. Volume 49:Issue 1(2021)
• Page Start: 19
• Page End: 24
• Publication Date: 2021
• Subjects: Ophthalmology, -- Macular Degeneration, -- AMD, -- VEGF, -- PDT, -- Industry, -- academia; Medical laws and legislation -- United States -- Periodicals; Medical care -- Law and legislation -- United States -- Periodicals; Medical ethics -- Periodicals; Jurisprudence -- Periodicals; Legislation, Medical -- Periodicals; Legislation, Nursing -- Periodicals; Ethics -- Periodicals; Forensic Medicine -- Periodicals; Nursing -- Periodicals; Medicine -- Periodicals; Societies -- Periodicals; Medical care -- Law and legislation; Medical ethics; Medical laws and legislation; United States; Periodicals; 344.73041
• DOI: 10.1017/jme.2021.4
• Languages: English
• ISSNs: 1073-1105

Abstract

Abstract: The development of photodynamic therapy and anti-vascular endothelial growth factor agents have revolutionized the treatment of retinal diseases, transforming the retina subspecialty by ushering in an age of pharmacological treatments for a wide range of diseases, including age-related macular degeneration (AMD).